Evonik Industries, one of the world's leading providers of
products based on methacrylate chemistry, is presenting
its new line of VISIOMER® Terra products at the American
Coatings Show in Atlanta, Georgia. Recently, the
Acrylic Monomers Business Line began bundling methacrylate
monomers based to a significant degree on renewable
resources under the product family VISIOMER® Terra.
VISIOMER® Terra showcases the partially bio-based products that
are already part of the Acrylic Monomers' portfolio and is expected
to continue growing in the future. "Thanks to VISIOMER® Terra, we
can already offer our customers products that combine
outstanding properties for end-use applications with a source of
bio-based raw materials. Developing new products based on
renewable resources is a fixed component of our development
work. We also continuously evaluate potential options for
manufacturing existing products from bio-based raw materials," explains Hans-Peter Hauck, head of the Acrylic Monomers Business
Line.
VISIOMER® Terra IBOMA allows manufacturers to formulate
environmentally safe coatings while keeping VOC content low.
VISIOMER® Terra C17.4-MA and VISIOMER® Terra C13-MA increase
hydrophobicity in resin systems, thereby improving resistance to
water and solvents.
In addition to the broad portfolio of specialty methacrylates that
Evonik Industries produces and markets throughout the world
under the VISIOMER® name, the brand also includes MMA, GMAA,
n- and i-BMA, and hydroxy methacrylates.
About Evonik
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of
the company form the heart of Evonik's corporate strategy. Its activities focus on
the key megatrends health, nutrition, resource efficiency and globalization. Evonik
benefits specifically from its innovative prowess and integrated technology
platforms.
Evonik is active in over 100 countries around the world. In fiscal 2013 more than
33,500 employees generated sales of around €12.9 billion and an operating profit
(adjusted EBITDA) of about €2.0 billion.
Forward Looking Statements
In so far as forecasts or expectations are expressed in this press release or where
our statements concern the future, these forecasts, expectations or statements
may involve known or unknown risks and uncertainties. Actual results or
developments may vary, depending on changes in the operating environment.
Neither Evonik Industries AG nor its group companies assume an obligation to
update the forecasts, expectations or statements contained in this release.
Source: Evonik